PROVIDER PROFILE · NPI 1457363681

Lwin Cho

Internal MedicineBrooklyn, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

7,158

Beneficiaries

—

Total drug cost

$1.1M

Distinct drugs

Brand share

32.4%

Top prescribed drugs

Atorvastatin Calcium568 claims

Amlodipine Besylate529 claims

Losartan Potassium331 claims

Metformin Hcl284 claims

Tamsulosin Hcl223 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Lwin Cho's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION	137	594

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION	92	298
Wayne Scott Ophthalmology · Brooklyn, NY	28	49

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history